Respons over for PREZISTA co- administreret med ritonavir (600/ 100 mg x 2) efter darunavir - fænotype ved baseline *:
Response (HIV-1 RNA < 50 copies/ml at week 24) to PREZISTA co-administered with ritonavir (600/100 mg b.i.d.) by baseline darunavir phenotype and by use of enfuvirtide: